MGF

Growth factor splice variant · Also known as Mechano Growth Factor, IGF-1Ec, MGF Peptide

What is MGF?

A naturally occurring splice variant of IGF-1 produced locally in muscle tissue after mechanical stress. It activates satellite cells for muscle repair but has a half-life of only minutes without PEGylation.

MGF (mechano growth factor) is the product of an alternative splicing event of the IGF-1 gene that occurs in response to muscle damage from exercise or injury. Unlike systemic IGF-1, MGF acts locally to activate muscle satellite cells, the stem cells responsible for muscle repair and hypertrophy.

Key takeaway: MGF is the body's natural muscle repair signal with a very short half-life. It works locally at the site of muscle damage, making it mechanistically distinct from its PEGylated version.

Benefits & evidence

Satellite cell activation Moderate confidence
Muscle repair Preliminary confidence
Local tissue recovery Preliminary confidence

How it works

When muscle fibers are mechanically stressed (resistance training, stretching, injury), the IGF-1 gene undergoes alternative splicing to produce MGF instead of the standard IGF-1Ea isoform.

MGF has a unique C-terminal E domain that activates satellite cells (muscle stem cells) to proliferate but not yet differentiate. This expands the pool of repair cells available. The standard IGF-1Ea isoform, produced later, then signals these expanded satellite cells to differentiate and fuse with damaged muscle fibers.

Native MGF is rapidly degraded by proteases, giving it a half-life of just a few minutes. This is why PEG-MGF was developed, though some researchers prefer the native form for its localized, pulsatile action at injection sites.

Dosing information

Typical dosing protocol
Starting dose

100-200 mcg

Post-workout
Maintenance dose

200 mcg

Post-workout, 2-3x per week

Injected locally into the trained muscle immediately post-workout when natural MGF production peaks. The very short half-life means timing matters.

Side effects

Most side effects tend to improve as your body adjusts.

Injection site pain Common
Hypoglycemia Moderate
Localized swelling Common

Research (10 studies)